The company, which follows the July-June financial year, had reported a profit after tax of ₹210.69 crore in the corresponding quarter of the previous fiscal.
Its revenue from operations of Procter & Gamble Hygiene and Health Care Ltd (PGHH) marginally fell by 0.28% to ₹1,135.16 crore during the quarter under review. It was ₹1,138.35 crore a year ago.
Also Read: Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4%
“The volume growth in the industry continues to be muted. The company witnessed growth in the feminine care category and continued to make progress on improving the structural profitability of the business in the quarter,” said an earnings statement from PGHH.
PGHH’s total expense, which operates in the healthcare and feminine care segment with brands Vicks and Whisper in its portfolio, declined 1.3% to ₹858.29 crore in the September quarter.
The total income of the Proctor & Gamble entity in the September quarter, which includes other income, was ₹1,143.66 crore, marginally down on a year-on-year basis.
Also Read: L&T Q2 numbers beat the Street; net profit up 5% at ₹3,395 crore, revenue spikes 21%
Shares of Procter & Gamble Hygiene and Health Care Ltd on Wednesday were trading at ₹16,291.70 on BSE in the afternoon trade, down 0.77% from the previous close.
First Published: Oct 30, 2024 11:22 PM IST